Jack W. Singer
2016
In 2016, Jack W. Singer earned a total compensation of $557.8K as Executive Vice President, Chief Scientific Officer, Interim Chief Medical Officer and Global Head of Translational Medicine at CTI BioPharma, a 83% decrease compared to previous year.
Compensation breakdown
Bonus | $90,000 |
---|---|
Option Awards | $34,800 |
Salary | $400,000 |
Other | $32,994 |
Total | $557,794 |
Singer received $400K in salary, accounting for 72% of the total pay in 2016.
Singer also received $90K in bonus, $34.8K in option awards and $33K in other compensation.
Rankings
In 2016, Jack W. Singer's compensation ranked 10,797th out of 14,075 executives tracked by ExecPay. In other words, Singer earned more than 23.3% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 10,797 out of 14,075 | 23rd |
Division Manufacturing | 4,192 out of 5,489 | 24th |
Major group Chemicals And Allied Products | 1,488 out of 1,895 | 22nd |
Industry group Drugs | 1,195 out of 1,538 | 22nd |
Industry Pharmaceutical Preparations | 936 out of 1,176 | 20th |
Source: SEC filing on March 28, 2017.
Singer's colleagues
We found five more compensation records of executives who worked with Jack W. Singer at CTI BioPharma in 2016.
2016
James Bianco
CTI BioPharma
Chief Executive Officer
2016
Bruce Seeley
CTI BioPharma
Secretary
2016
Matthew Plunkett
CTI BioPharma
Executive Vice President, Chief Business Officer
2016
Richard Love
CTI BioPharma
Chief Executive Officer
2016
Louis Bianco
CTI BioPharma